Seeking Alpha

Volcano Corporation (VOLC)

  • Dec. 17, 2014, 12:46 PM
    | Comment!
  • Dec. 17, 2014, 9:13 AM
    | Comment!
  • Aug. 8, 2014, 3:49 PM
    • First the good news:
    • Tekmira (TKMR +38.1%) on a massive 25M share turnover; Raptor Pharmaceuticals (RPTP +28.2%) on a 4x surge in volume; Clovis Oncology (CLVS +11.6%) on 50% higher volume; RadNet (RDNT +20.4%) on 2x higher volume and Relypsa (RLYP +15%) on 2x higher volume.
    • Now the bad news:
    • TearLab (TEAR -21.2%) on 4x higher volume; Masimo (MASI -10.6%) on 3x higher volume; Volcano (VOLC -19.9%) on a 12x surge in volume and Hanger (HGR -24.9%) on a 16x surge in volume.
    | 1 Comment
  • Aug. 8, 2014, 12:47 PM
    | Comment!
  • Oct. 29, 2013, 12:45 PM
  • Oct. 29, 2013, 9:12 AM
  • Aug. 6, 2013, 2:35 PM
    • Volcano (VOLC +9.8%) extends yesterday's post-session gains after the medical equipment manufacturer's Q2 report topped estimates.
    • The company affirms its FY13 EPS of 0.03 to $0.05, in-line with the Street view looking for $0.05.
    • Revenue is projected in a range of $394M to $400M, also bracketing consensus of $395.8M.
    • Canaccord ups the shares to Buy on the back of the report, saying that improving trends in its core IVUS business, plus easing Y/Y comps, strong margin expansion potential and several other catalysts on the horizon point to a more favorable risk/reward profile at current trading levels.
    • Shares are moving on nearly four times 30-day average volume.
    | Comment!
  • Mar. 8, 2013, 10:47 AM
    Volcano (VOLC +1.9%) moves up after Credit Suisse ups the shares from Neutral to Outperform with a $27 price target. The firm says the overhang from a $300M convert in December has created a buying opportunity, noting that it's a unique growth story among med-tech with exposure to fractional flow reserve that will drive double digit overall sales and EPS growth.
    | Comment!
  • Feb. 22, 2013, 12:53 PM
    Midday top 10 gainers: WBMD +25%. EDAP +24%. PSDV +24%. ARUN +22%. BLOX +17%. SSTK +16%. FIRE +15%. B +15%. AVG +12%. RKUS +12%.
    Midday top 10 losers: ETRM -20%. MMSI -19%. WIFI -18%. FRO -14%. NVGN -12%. CBMX -12%. VOLC -11%. GMXR -16%. RCKY -11%. REED -11%.
    | Comment!
  • Feb. 22, 2013, 11:37 AM
    Shares of Volcano (VOLC -14.6%) slip after revising guidance lower late yesterday, saying revenue for 2013 will come in between $406M to $412M, on an EPS of $0.08 to $0.11 per share. Goldman cut the stock to Neutral from Conviction Buy on the news, saying the lower outlook points to continued pressure on its base business, slowing new growth drivers, and lower EBIT leverage. William Blair also reduces it to Market Perform, while First Analyis downgrades it to Equal Weight.
    | Comment!
  • Jan. 7, 2013, 4:29 PM
    Volcano Corporation (VOLC) gives an update on its Q4, saying it expects total revenue of $102.5M, in-line with the Street view, bringing expected FY12 revenues to approximately $382M, also in line with the consensus view. Complete results are to be available in late February. Shares -1.5% AH.
    | Comment!
  • Dec. 12, 2012, 11:18 AM
    Volcano Corp. (VOLC -1.8%) slips today after Credit Suisse downgraded the shares to Neutral and cut its price target from $32.00 to $27.00 . The firm says there's little clarity on its upcoming M&A issues, and VOLC will have to execute solidly in order to create shareholder value. There's potential for further dilution if funds are spent on earlier stage/limited revenue assets.
    | Comment!
  • Dec. 4, 2012, 12:24 PM
    Medical device manufacturer Volcano Corp. (VOLC -5.1%) slides today after announcing its intention to offer $350M in convertible senior notes due December 1, 2017, with an additional $52M to cover over-allotments.
    | Comment!
  • May. 3, 2012, 2:07 PM
    Volcano (VOLC +3.4%) moves higher despite coming up short on its Q1 results late yesterday, as Goldman raises the shares to Conviction Buy with a potential 28% upside. Goldman calls the company a "unique asset," noting that its fractional flow reserve business is ramping up and sees strong trends developing in its medical franchise business.
    | Comment!
  • Mar. 9, 2012, 9:58 AM
    Medical device maker Volcano (VOLC +3.5%) trades higher on an upgrade to Buy from Goldman. The firm cites "increased confidence" in Volcano's rapidly-growing Fractional Flow Reserve business, which can reduce healthcare costs by "improving patient selection and clinical outcomes" for coronary stent procedures.
    | Comment!
  • Jan. 5, 2012, 8:44 AM
    Shares of Volcano (VOLC) trade lower, down 2.5% premarket, after BMO Capital downgrades shares of the healthcare tech concern to Market Perform from Outperform.
    | Comment!
Visit Seeking Alpha's
VOLC vs. ETF Alternatives
Company Description
Volcano Corp design, develop, manufacture and commercialize a suite of precision guided therapy tools including intravascular ultrasound, or IVUS, and fractional flow reserve, or FFR, products.